How soon can buprenorphine‑naloxone (Suboxone) be started after stopping oral or injectable naltrexone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Buprenorphine Initiation After Naltrexone Discontinuation

For oral naltrexone, wait 2-3 days before starting buprenorphine; for extended-release injectable naltrexone, wait 24-30 days before initiating buprenorphine. 1

Oral Naltrexone

The antagonist effects of oral naltrexone persist for 2-3 days after the last dose due to accumulation of its active metabolite, 6-β-naltrexol, which has a 13-hour half-life. 1 This extended blockade means that starting buprenorphine too early will result in inadequate symptom control, as naltrexone will continue to occupy opioid receptors and prevent buprenorphine from binding effectively.

Practical Algorithm for Oral Naltrexone:

  • Day 0: Last dose of oral naltrexone 1
  • Days 1-2: Allow naltrexone clearance; monitor for emerging withdrawal symptoms 1
  • Day 3 or later: Confirm withdrawal using Clinical Opiate Withdrawal Scale (COWS score >8), then initiate buprenorphine 4-8 mg sublingual 2
  • Reassess after 30-60 minutes: Give additional 2-4 mg doses at 2-hour intervals if withdrawal persists 2

Extended-Release Injectable Naltrexone (Vivitrol)

Extended-release naltrexone requires a dramatically longer waiting period of 24-30 days after the last injection before buprenorphine can be started. 1 This extended timeline reflects the depot formulation's prolonged release kinetics and the risk of severe receptor up-regulation that occurs during long-term naltrexone maintenance. 1

Critical Safety Consideration:

Patients maintained on extended-release naltrexone may develop up-regulation of opioid receptors, making them paradoxically more sensitive to respiratory depression if full opioid agonists are used prematurely. 1 This same mechanism means that attempting buprenorphine induction too early will be completely ineffective and may precipitate severe withdrawal.

Practical Algorithm for Extended-Release Naltrexone:

  • Week 0: Last injection of extended-release naltrexone 1
  • Weeks 1-3: Naltrexone continues to block opioid receptors; no buprenorphine should be attempted 1
  • Week 4 (Day 24-30): Earliest safe window to assess for withdrawal and initiate buprenorphine 1
  • Confirm withdrawal: Use COWS score >8 before first buprenorphine dose 2
  • Initial dose: 4-8 mg sublingual buprenorphine based on withdrawal severity 2

Buprenorphine Induction Protocol After Naltrexone

Once the appropriate waiting period has elapsed, follow standard buprenorphine induction:

Day 1 of Induction:

  • Verify COWS score >8 (moderate to severe withdrawal) before administering any buprenorphine 2
  • Give 4-8 mg sublingual based on withdrawal severity 2
  • Reassess after 30-60 minutes and give additional 2-4 mg every 2 hours if needed 2
  • Target Day 1 total: 8 mg (range 4-8 mg) 2

Day 2 and Maintenance:

  • Standard maintenance dose: 16 mg daily (range 4-24 mg) 2
  • Prescribe buprenorphine/naloxone combination for 3-7 days or until follow-up 2
  • Provide naloxone kit and overdose prevention education at discharge 2

Common Pitfalls to Avoid

Never attempt buprenorphine induction before the recommended waiting periods, as residual naltrexone will block buprenorphine's therapeutic effects and leave the patient in uncontrolled withdrawal. 1 The case report demonstrating successful buprenorphine "rescue" from naltrexone-induced withdrawal 3 involved accidental naltrexone ingestion in an acute setting—this does not change the recommended waiting periods for planned transitions.

Do not confuse the timing requirements: The 72-hour wait required when transitioning from methadone to buprenorphine 2 is completely different from the naltrexone clearance periods. Methadone's long half-life creates risk of precipitated withdrawal, whereas naltrexone's receptor blockade prevents buprenorphine from working at all.

For extended-release naltrexone specifically, attempting earlier induction (before 24-30 days) will fail because depot naltrexone maintains therapeutic blood levels for the entire month. 1 There is no way to accelerate this clearance.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Medications for Managing Opioid Withdrawal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the equivalent Suboxone (buprenorphine/naloxone) dosing for an adult patient with opioid use disorder converting from Belbuca (buprenorphine) 450mcg twice daily (bid)?
What are the guidelines for safely discontinuing Suboxone (buprenorphine) in a patient with a history of opioid use disorder, including recommended comfort medications and dosages?
Does buprenorphine have a lower misuse risk than methadone for opioid use disorder?
Can Suboxone (buprenorphine/naloxone) cause Amyotrophic Lateral Sclerosis (ALS)-like symptoms?
Can I withdraw from Suboxone (buprenorphine/naloxone) after a short induction and only one day of 8/2mg TID (three times a day)?
What is the role of cytodiagnosis (including fine‑needle aspiration cytology, imprint/brush cytology, scraping, and blister‑fluid aspiration) in dermatology, and what are its indications and limitations?
How should cellulitis of the arm and elbow be managed in a diabetic patient after trauma who is already taking oral amoxicillin‑clavulanate (Augmentin)?
How long does olmesartan (angiotensin II receptor blocker) take to begin lowering blood pressure and reach its full antihypertensive effect?
In a patient with severe vertebral artery stenosis whose chronic antihypertensive regimen was held during an acute gallbladder infection and was treated only with PRN antihypertensives for systolic blood pressure >180 mm Hg, did the subsequent stroke result from uncontrolled hypertension rather than malpractice?
In a patient with rapidly progressive symmetric limb weakness, ascending from the legs, areflexia, and recent infection, what is the likely diagnosis, appropriate diagnostic work‑up, and first‑line treatment?
What antibiotics should be used to treat a male patient with a urine culture positive for beta‑hemolytic streptococcus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question